Corteva, Inc. $CTVA Position Lifted by Keybank National Association OH

Keybank National Association OH grew its stake in Corteva, Inc. (NYSE:CTVA) by 94.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 123,914 shares of the company’s stock after purchasing an additional 60,053 shares during the period. Keybank National Association OH’s holdings in Corteva were worth $9,622,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also made changes to their positions in the stock. New York Life Investment Management LLC boosted its stake in Corteva by 14.8% during the third quarter. New York Life Investment Management LLC now owns 123,354 shares of the company’s stock worth $9,578,000 after buying an additional 15,941 shares during the last quarter. Welch & Forbes LLC grew its holdings in Corteva by 1,759.2% in the 3rd quarter. Welch & Forbes LLC now owns 115,420 shares of the company’s stock valued at $8,962,000 after buying an additional 109,212 shares in the last quarter. Fulcrum Asset Management LLP increased its stake in shares of Corteva by 3.8% in the 3rd quarter. Fulcrum Asset Management LLP now owns 70,657 shares of the company’s stock worth $5,657,000 after acquiring an additional 2,566 shares during the last quarter. StoneRidge PMG Advisors LLC acquired a new stake in shares of Corteva in the 3rd quarter worth $489,000. Finally, Beverly Hills Private Wealth LLC acquired a new stake in shares of Corteva in the 3rd quarter worth $200,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CTVA has been the topic of several analyst reports. Bank of America lifted their price target on Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a report on Monday, July 20th. Weiss Ratings lowered shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. Zacks Research cut shares of Corteva from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 6th. JPMorgan Chase & Co. raised shares of Corteva from a “neutral” rating to an “overweight” rating and set a $19.00 target price on the stock in a research note on Tuesday, October 6th. Finally, New Street Research set a $17.00 target price on shares of Corteva in a report on Monday, October 5th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Corteva currently has a consensus rating of “Moderate Buy” and a consensus target price of $56.91.

Key Corteva News

Investors following CTVA have been watching these news items:

• Positive Sentiment: Corteva said new-product sales growth and operational execution helped cushion market headwinds. One report also showed adjusted Q3 EPS of $0.06, above the $0.02 consensus estimate, though coverage described the overall quarter as weak and results varied by measure. Corteva Q3 results and outlook
• Neutral Sentiment: Investors bought 2,661 call options, about 149% above the average volume. This signals increased trading activity but does not establish a clear direction for the shares.
• Negative Sentiment: Corteva lowered its 2026 EPS guidance to $0.76–$0.80, below the roughly $1.07 analyst consensus. The company cited weaker-than-expected conditions in Brazil, where the CEO warned the slump could continue. Reuters report on Brazil weakness and forecast cut

Corteva Price Performance

CTVA stock opened at $9.26 on Friday. The business has a fifty day moving average of $38.81 and a two-hundred day moving average of $69.88. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The stock has a market cap of $6.18 billion, a price-to-earnings ratio of 3.20, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. Corteva, Inc. has a 52-week low of $9.14 and a 52-week high of $90.97.

Corteva Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Tuesday, December 1st will be issued a dividend of $0.05 per share. The ex-dividend date is Tuesday, December 1st. This represents a $0.20 dividend on an annualized basis and a dividend yield of 2.2%. This is a drop from Corteva’s previous quarterly dividend of $0.18. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

Corteva Company Profile

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.